The global COVID-19 pandemic has led to changes in public health measures causing significant disruption across lung cancer screening, diagnosis, treatment and management pathways. The pandemic has presented many challenges for lung cancer patients. These measures have also impacted people's behaviour and their interaction with the healthcare system. Therefore, increased knowledge of the broader as well as biological impacts of COVID-19 on lung cancer patients' health, is required.